Clinical Trials Browser

Phase 3 × inavolisib × 30 days × Clear all

NCT05862285 2026-03-13

UmbrellaMAX

Phase 3 Recruiting

Neoplasms

NCT06790693 2026-03-06

INAVO123

Phase 3 Recruiting

Breast Neoplasms